Top Markets
Coin of the day
Neoleukin Therapeutics, Inc. Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics, Inc.

NLTX
Pozycja w akcjach #26682
Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused... Neoleukin Therapeutics, Inc. (NLTX) is a biopharmaceutical enterprise focused on developing immune-based treatments for conditions such as cancer, inflammatory responses, and autoimmune diseases, utilizing its proprietary protein design technology. The company's leading investigational therapy is NL-201, a novel protein meticulously crafted to emulate the therapeutic effects of the IL-2/IL-15 cytokines. This product candidate is intended for the management of various malignancies, including renal cell carcinoma and melanoma. The organization, founded in 2003, was previously known as Aquinox Pharmaceuticals, Inc. before officially changing its name to Neoleukin Therapeutics, Inc. in August 2019. Its operations are based out of Seattle, Washington.
Cena akcji
$3.49
Ostatnia synchronizacja: 2023-12-19
Kapitalizacja rynkowa
$38.68M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Neoleukin Therapeutics, Inc. (NLTX)

Kategoria

Historia ceny akcji dla Neoleukin Therapeutics, Inc. (NLTX)
Najwyższa cena zamknięcia: $3.45 dnia 2023-12-01

Najniższa cena zamknięcia: $64.26 dnia 2014-03-01
Historia cen akcji firmy Neoleukin Therapeutics, Inc. od 2014 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 54.08%
2022 -91.29%
2021 -59.35%
2020 43.82%
2019 289.17%
2018 -79.56%
2017 -28.51%
2016 28.68%
2015 63.39%
2014 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$171.67 -
DE
$163.33 25.54%
DE
$38.00 22.72%
JP
$220.12 32.96%
CH
$21.01 11.96%
IN